BioNTech SE (BNTX) Net Income towards Common Stockholders Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -27.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.12% |
| Sep 30, 2025 | -62.98% |
| Jun 30, 2025 | -28.83% |
| Mar 31, 2025 | -27.45% |
| Dec 31, 2024 | 4,146.19% |
| Sep 30, 2024 | -49.83% |
| Jun 30, 2024 | -28.81% |
| Mar 31, 2024 | -29.88% |
| Dec 31, 2023 | 12,778.82% |
| Sep 30, 2023 | 9.73% |
| Jun 30, 2023 | -60.46% |
| Mar 31, 2023 | 155.23% |
| Dec 31, 2022 | 236.34% |
| Sep 30, 2022 | 281.96% |
| Jun 30, 2022 | 283.19% |
| Mar 31, 2022 | 435.48% |
| Dec 31, 2021 | -95.92% |
| Sep 30, 2021 | 302.54% |